Tag

Combination Vaccine

All articles tagged with #combination vaccine

health2 years ago•2 min saved

Moderna Begins Phase 3 Trial for Combo Flu and COVID Vaccine

Moderna has initiated a phase III clinical trial for a combination influenza and COVID-19 vaccine, dosing its first participant. The trial will assess the safety and efficacy of the combo vaccine compared to separate flu and COVID vaccines in two groups of adults. Previous trials showed promising results, with the combination vaccine generating antibody levels similar to licensed standalone influenza and COVID vaccines. Moderna aims to reduce the burden of respiratory diseases by providing simultaneous protection against flu and COVID in a single dose, potentially increasing vaccine coverage rates. The company estimates regulatory approval for the combination vaccine by 2025. Other companies, including Pfizer-BioNTech and Novavax, are also investigating flu-COVID combination vaccines. Public health officials recommend getting annual flu and COVID-19 shots for individuals aged 6 months and older.

via ABC News|

#clinical-trial #combination-vaccine #covid-19-vaccine

health2 years ago•2 min saved

Moderna Begins Phase 3 Trial for Combined Flu and COVID Vaccine

Moderna has administered the first dose in a phase III clinical trial for a combination influenza and COVID-19 vaccine. The trial will evaluate the safety and efficacy of the combo vaccine compared to separate flu and COVID vaccines. The combination vaccine aims to reduce the burden of respiratory diseases by providing simultaneous protection against both viruses in a single dose. Moderna estimates that regulatory approval for the combination vaccine could be achieved by 2025. Other companies, including Pfizer-BioNTech and Novavax, are also investigating flu-COVID combination vaccines. Public health officials recommend getting annual flu and COVID-19 shots to minimize the risk of severe illness.

via Yahoo! Voices|

#clinical-trial #combination-vaccine #covid-19-vaccine

health2 years ago•6 min saved

Moderna's Dual COVID-Flu Vaccine Shows Promising Trial Results

Moderna has announced positive interim results from the Phase 1/2 trial of mRNA-1083, its combination vaccine against influenza and COVID-19. The vaccine showed strong immunogenicity against both viruses and had an acceptable safety profile. Moderna plans to begin a Phase 3 trial of mRNA-1083 in adults aged 50 and above and aims for potential regulatory approval in 2025. The company believes that combination vaccines offer an opportunity to improve compliance and convenience for individuals and healthcare systems. Influenza and COVID-19 pose significant seasonal burdens, and Moderna aims to address this threat through its combination respiratory vaccines.

via Moderna Investor Relations|

#combination-vaccine #covid-19 #health

health2 years ago•1 min saved

"Promising Results Propel Moderna's Combined Covid and Flu Vaccine to Final Trial Stage"

Moderna's combination vaccine targeting Covid and the flu, mRNA-1083, has shown positive results in an early to mid-stage study and will move to a final stage trial in adults aged 50 and above this year. The vaccine generated a strong immune response similar to or greater than currently available flu vaccines and Moderna's bivalent Covid vaccine. The company believes combination vaccines will simplify protection against respiratory viruses and hopes to win regulatory approval by 2025. Moderna is also developing a combination shot targeting the flu and RSV, as well as a vaccine targeting all three respiratory viruses: Covid, flu, and RSV. Pfizer and BioNTech are also developing a vaccine targeting both Covid and the flu, with a phase one trial underway and expected launch in 2024 or later.

via CNBC|

#combination-vaccine #covid #final-stage-trial